Haemolytic and proteinase activities in clinical isolates of Candida parapsilosis and Candida tropicalis with reference to the isolation anatomic site

Mycoses

Volumn 54, Issue 4, 2011, Pages

  Franca E J G ^a   Furlaneto Maia, L ^b   Quesada, R M B ^a   Favero, D ^a   Oliveira, M T ^a   Furlaneto, M C ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

Author keywords

Anatomic sites; Haemolytic factor; Non albicans Candida; Proteinase

Indexed keywords

PROTEINASE;

ARTICLE; BLOOD ANALYSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; HEMOLYSIS; HUMAN; IN VITRO STUDY; MICROBIAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; TRACHEA MUCUS;

BLOOD; CANDIDA; HEMOLYSIN PROTEINS; HUMANS; NAILS; PEPTIDE HYDROLASES; SKIN; SPUTUM; VIRULENCE FACTORS;

CANDIDA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 79959238998     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01825.x     Document Type: Article

References (33)

1. Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Mycoses 2007; 50: 52-7.
2. Caggiano G, Iatta R, Laneve A, Manca F, Montagna MT. Observational study on candidemia at a university hospital in southern Italy from 1998 to 2004. Mycoses 2008; 51: 123-8.
3. Malafiej E, Adamiec AC, Tworzyanska U. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study. Mycoses 2009; 52: 149-53.
4. Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol 2009; 144: 68-71.
5. Almirante B, Rodríguez D, Cuenca-Estrella M et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006; 44: 1681-5.
6. Colombo AL, Nucci M, Park BJ et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centres. J Clin Microbiol 2006; 44: 2816-23.
7. Nucci C, Colombo AL. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 2007; 58: 77-82.
8. Anunnatsiri S, Chetchotisakd P, Mootsikapun P. Fungemia in non-HIV-infected patients: a five-year review. Int J Infect Dis 2009; 13: 90-6.
9. Brilhante RSN, Cordeiro RA, Medrano DJA et al. Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects. Mem Inst Oswaldo Cruz 2005; 100: 131-5.
10. Martins EA, Guerrer LV, Cunha KC, Soares MMC, Almeida MTG. Onychomycosis: clinical, epidemiological and mycological study in the municipality of São José do Rio Preto. Rev Socied Bras Med Trop 2007; 40: 596-8.
11. Manzano-Gayosso P, Hernández-Hernández F, Méndez-Tovar LJ et al. Onychomycosis incidence in type 2 diabetes mellitus patients. Mycopathologia 2008; 166: 41-5.
12. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001; 9: 327-35.
13. Haynes K. Virulence in Candida species. Trends Microbiol 2001; 9: 591-6.
14. Odds FC. Candida and Candidosis, 2nd edn. London, UK: Bailliere Tindall, 1988.
15. Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun 1994; 62: 5154-6.
16. Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 2001; 39: 2971-4.
17. Yigit N, Aktas E. Comparison of the efficacy of different blood medium in determining the hemolytic activity of Candida species. J Mycol Med 2009; 19: 110-5.
18. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48: 365-77.
19. De Bernardis F, Mondello F, San Millàn R, Ponón J, Cassone A. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol 1999; 37: 3481-6.
20. Kantarcioglu AS, Yücel A. Phospholipase and protease activities in clinical Candida isolates with reference to the source of strains. Mycoses 2002; 45: 160-5.
21. Dagdeviren M, Cerikcioglu N, Karavus M. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalized patients. Mycoses 2005; 48: 321-6.
22. Kumar CPG, Kumar SSJ, Menon T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 2006; 161: 213-8.
23. Borg M, Ruchel R. Expression of extracellular acid proteinase by proteolytic Candida spp during experimental infection of oral tracheal secretion. Infect Immun 1988; 56: 626-31.
24. Ruchel R, Zimmermann F, Boning-Stutzer B, Helmchen U. Candidiasis visualized by proteinase-directed immunofluorescence. Virchows Arch A Pathol Anat Histopathol 1991; 419: 199-202.
25. Furlaneto-Maia L, Specian AF, Bizerra FC, Oliveira MT, Furlaneto MC. In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia 2008; 166: 209-17.
26. Li YL, Leaw SN, Chen JH, Chang HC, Chang TC. Rapid identification of yeasts commonly found in positive blood cultures by amplification of the internal transcribed spacer regions 1 and 2. Eur J Clin Microbiol Infect Dis 2003; 22: 693-6.
27. Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005; 43: 284-92.
28. Bullen J. The significance of iron in infection. Rev Infect Dis 1981; 3: 1127-38.
29. Weinberg ED. Iron and infection. Microbiol Rev 1978; 42: 45-66.
30. Watanabe T, Tanaka H, Nakao N, Mikami T, Matsumoto T. Hemoglobin is utilized by Candida albicans in the hyphal form but not yeast form. Biochem Biophys Res Commun 1997; 232: 350-3.
31. Watanabe T, Takano M, Murakami M et al. Characterization of a haemolytic factor from Candida albicans. Microbiology 1999; 145: 689-94.
32. Schaller M, Schafer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 1998; 29: 605-15.
33. Schaller M, Korting HC, Schafer W, Bastert J, Chen W, Hube B. Secreted aspartic proteinase (sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 1999; 34: 169-80.